Journal Information
Vol. 45. Issue S4.
HEMO 2023
Pages S378-S379 (October 2023)
Share
Share
Download PDF
More article options
Vol. 45. Issue S4.
HEMO 2023
Pages S378-S379 (October 2023)
Full text access
PROGNOSTIC SIGNIFICANCE OF LMR AND RDW IN PATIENTS WITH DIFFUSE LARGE B CELL LYMPHOMA
Visits
198
CA Assisa, LM Fogliattoa, L Damascenoa, MS Vieirab, LN Rottaa
a Universidade Federal de Ciências da Saúde de Porto Alegre (UFCSPA), Porto Alegre, Brazil
b Laboratório Zanol, Porto Alegre, Brazil
This item has received
Article information
Special issue
This article is part of special issue:
Vol. 45. Issue S4

HEMO 2023

More info
Objective

The lymphocyte monocyte ratio (LMR) and red blood cell distribution width (RDW) are being recognized as useful prognostic tools for patients with Diffuse Large B Cell Lymphoma (DLBCL).

Methodology

We retrospectively analysed 98 data of DLBCL patients diagnosed between 2008 and 2018 from three hospitals in Porto Alegre/RS/Brazil and collected data form blood count cells and DHL.

Results

Patients with LMR ≤1.90 were in advanced stage of the disease (Ann Arbor stages III and IV p = 0.011), had a high LDH (p < 0.001) and age ≤60 years (p = 0.026). Patients with RDW ≥14.25 were in advanced stage of the disease (p = 0.023) with these being older (6 years, p = 0.049). RDW and LMR showed significant prognostic of overall survival (OS) in univariate (p = 0.003 and p = 0.006) and multivariate analyses (p = 0.0018 and p = 0.021), respectively.

Conclusion

RDW and LMR are important independent prognostic factors. An elevated RDW and a decreased LMR are associated with a bad/worst prognosis in newly diagnosed DLBCL. RDW is the most adverse prognostic factor and could be included prognostic scores for DLBCL.

Full text is only aviable in PDF
Idiomas
Hematology, Transfusion and Cell Therapy
Article options
Tools